返回
Complement(ing) thromboinflammation and pathogenesis
DOI:10.1016/j.it.2024.04.001.png)
摘要
En 中文
The persistence or recurrence of symptoms after acute SARS-CoV2 infection, termed 'long COVID', presents a formidable challenge to global healthcare systems. Recent research by Cervia-Hasler and colleagues delves into the intricate immunological landscape in patients with long COVID, demonstrating an interplay between complement and coagulation, driven by antiviral antibodies and tissue damage.
Keyword:
COVID-19
期刊
IF:
13.9
论文数:
2.7K
被引数:
1.7W
机构
引用论文
Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?
CLINICAL MEDICINE
IF3.9
The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models白细胞亚群对动脉粥样硬化的多方面贡献: 来自小鼠模型的经验教训
没有更多内容

